Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Lipid Res ; 60(5): 972-980, 2019 05.
Article in English | MEDLINE | ID: mdl-30796085

ABSTRACT

The widely expressed lysophosphatidic acid (LPA) selective receptor 4 (LPAR4) contributes to vascular development in mice and zebrafish. LPAR4 regulates endothelial permeability, lymphocyte migration, and hematopoiesis, which could contribute to atherosclerosis. We investigated the role of LPAR4 in experimental atherosclerosis elicited by adeno-associated virus expressing PCSK9 to lower LDL receptor levels. After 20 weeks on a Western diet, cholesterol levels and lipoprotein distribution were similar in WT male and Lpar4Y/- mice (P = 0.94). The atherosclerotic lesion area in the proximal aorta and arch was ∼25% smaller in Lpar4Y/- mice (P = 0.009), and less atherosclerosis was detected in Lpar4Y/- mice at any given plasma cholesterol. Neutral lipid accumulation in aortic root sections occupied ∼40% less area in Lpar4Y/- mice (P = 0.001), and CD68 expression was ∼25% lower (P = 0.045). No difference in α-smooth muscle actin staining was observed. Bone marrow-derived macrophages isolated from Lpar4Y/- mice displayed significantly increased upregulation of the M2 marker Arg1 in response to LPA compared with WT cells. In aortic root sections from Lpar4Y/- mice, heightened M2 "repair" macrophage marker expression was detected by CD206 staining (P = 0.03). These results suggest that LPAR4 may regulate the recruitment of specific sets of macrophages or their phenotypic switching in a manner that could influence the development of atherosclerosis.


Subject(s)
Atherosclerosis/metabolism , Receptors, Purinergic/deficiency , Receptors, Purinergic/metabolism , Animals , Cells, Cultured , Lysophospholipids/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout
2.
J Neurochem ; 112(5): 1261-72, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20002522

ABSTRACT

Intense neuronal activity in the sensory retina is associated with a volume increase of neuronal cells (Uckermann et al., J. Neurosci. 2004, 24:10149) and a decrease in the osmolarity of the extracellular space fluid (Dmitriev et al., Vis. Neurosci. 1999, 16:1157). Here, we show the existence of an endogenous purinergic mechanism that prevents hypoosmotic swelling of retinal glial (Müller) cells in mice. In contrast to the cells from wild-type mice, hypoosmotic stress induced rapid swelling of glial cell somata in retinal slices from mice deficient in P2Y(1), adenosine A(1) receptors, or ecto-5'-nucleotidase (CD73). Consistently, glial cell bodies in retinal slices from wild-type mice displayed osmotic swelling when P2Y(1) or A(1) receptors, or CD73, were pharmacologically blocked. Exogenous ATP, UTP, and UDP inhibited glial swelling in retinal slices, while the swelling of isolated glial cells was prevented by ATP but not by UTP or UDP, suggesting that uracil nucleotides indirectly regulate the glial cell volume via activation of neuronal P2Y(4/6) and neuron-to-glia signaling. It is suggested that autocrine/paracrine activation of purinergic receptors and enzymes is crucially involved in the regulation of the glial cell volume.


Subject(s)
Cell Size , Neuroglia/cytology , Osmosis , Receptors, Purinergic/metabolism , Retina/cytology , Signal Transduction/physiology , 5'-Nucleotidase/deficiency , Adenine/analogs & derivatives , Adenine/pharmacology , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Animals , Barium Compounds/metabolism , Calcium/metabolism , Chlorides/metabolism , Cyclic AMP/metabolism , Drug Combinations , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Inositol 1,4,5-Trisphosphate Receptors/deficiency , Mice , Mice, Knockout , Neuroglia/drug effects , Neurons/drug effects , Neurons/metabolism , Osmolar Concentration , Potassium Channel Blockers/pharmacology , Purinergic Agonists , Purinergic Antagonists , Pyrimidine Nucleotides/pharmacology , Quaternary Ammonium Compounds/pharmacology , Receptors, Purinergic/deficiency , Signal Transduction/drug effects , Signal Transduction/genetics , Thionucleotides/pharmacology , Time Factors , Valerates/pharmacology , Xanthines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...